ABBOTT LABORATORIES — Director's Dealing 2007

Dec 11, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-12-07

Reporting Person: LIEPMANN HOLGER A (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-12-07	Common shares without par value	M	2454	$41.0317	Acquired	145961	Direct
2007-12-07	Common shares without par value	M	2200	$45.4488	Acquired	148161	Direct
2007-12-07	Common shares without par value	F	3450	$58.15	Disposed	144711	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-12-07	Option (right to buy)	$41.0317	M	2454	Disposed	2014-02-19	Common shares (2454)	Direct
2007-12-07	Option (right to buy)	$45.4488	M	2200	Disposed	2011-02-08	Common shares (2200)	Direct
2007-12-07	Option (right to buy)	$58.15	A	1731	Acquired	2014-02-19	Common shares (1731)	Direct
2007-12-07	Option (right to buy)	$58.15	A	1719	Acquired	2011-02-08	Common shares (1719)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	13834	Indirect
Common shares without par value	295	Indirect
Common shares without par value	296	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2007

F2: Reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.